INTERNATIONAL PATENT: BAYLOR COLLEGE OF MEDICINE, BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM FILES APPLICATION FOR "METHODS TO RAPIDLY DETECT METHYLTHIOADENOSINE AND RELATED METABOLITES DIRECTLY FROM PATIENT SAMPLES TO IDENTIFY 9P21 LOSS CANCERS AND TREATMENT STRATEGIES FOR PATIENTS"

GENEVA, April 30 -- BAYLOR COLLEGE OF MEDICINE (One Baylor PlazaHouston, Texas 77030), BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (210 West 7th StreetAustin, Texas 78701) filed a patent application (PCT/US2024/051744) for "METHODS TO RAPIDLY DETECT METHYLTHIOADENOSINE AND RELATED METABOLITES DIRECTLY FROM PATIENT SAMPLES TO IDENTIFY 9P21 LOSS CANCERS AND TREATMENT STRATEGIES FOR PATIENTS" on Oct 17, 2024. With publication no. WO/2025/085615, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): EBERLIN, Livia Schiavinato ...